Boston Therapeutics, Inc. Introductory Social Media Launch (www.bostonti.com)
16 janv. 2018 10h05 HE
|
Boston Therapeutics, Inc.
LAWRENCE, Mass., Jan. 16, 2018 (GLOBE NEWSWIRE) -- Boston Therapeutics, Inc. (OTCQB:BTHE) begun the roll-out of its new Multimedia Internet Platform. The redesigned website offers global insight...
Boston Therapeutics, Inc. Expands Partnership with APC to Distribute in Korea
14 déc. 2017 12h53 HE
|
Boston Therapeutics, Inc.
LAWRENCE, Mass., Dec. 14, 2017 (GLOBE NEWSWIRE) -- Following the extension of the licensing and distribution agreement with Asian based partner, Advance Pharmaceutical Company Limited (APC), a...
Boston Therapeutics, Inc. Announces New Dosing Regimen for BTI320
06 déc. 2017 12h12 HE
|
Boston Therapeutics, Inc.
LAWRENCE, Mass., Dec. 06, 2017 (GLOBE NEWSWIRE) -- Boston Therapeutics, Inc is pleased to announce that effective sugar reduction with the investigative BTI320 formulation requires only one tablet....
Boston Therapeutics Shareholder Update
17 nov. 2017 09h10 HE
|
Boston Therapeutics, Inc.
LAWRENCE, Mass., Nov. 17, 2017 (GLOBE NEWSWIRE) -- On November 16, 2017, Carl W. Rausch, CEO of Boston Therapeutics, Inc., headquartered in Lawrence MA, (OTCQB:BTHE) (“BTI” or the “Company”),...
BOSTON THERAPEUTICS Reports Data from the POC Asia Trial at the American Diabetes Association’s 77th Scientific Sessions
19 juin 2017 08h30 HE
|
Boston Therapeutics, Inc.
LAWRENCE, Mass., June 19, 2017 (GLOBE NEWSWIRE) -- Mr. Carl Rausch, CEO of Boston Therapeutics, Inc. (OTCQB:BTHE) and its Asian partner Advance Pharmaceutical Company Limited, Hong Kong had data...
Boston Therapeutics secures $1 Million financing for the first phase Multi-Centre International Ph II-III Trial
26 avr. 2017 11h14 HE
|
Boston Therapeutics
LAWRENCE, MA--(Marketwired - Apr 26, 2017) - Boston Therapeutics, Inc. (OTCQB: BTHE) and its Asian partner Advance Pharmaceutical Company Limited, Hong Kong, announced today the fully financed new...
Boston Therapeutics Business Update
07 févr. 2017 07h51 HE
|
Boston Therapeutics
LAWRENCE, MA--(Marketwired - Feb 7, 2017) - On February 1, 2017 Boston Therapeutics, Inc., headquartered in Lawrence MA, (OTCQB: BTHE) disclosed its restructured operations activity in a two...
Boston Therapeutics Announces Innovation Grant
13 oct. 2016 10h16 HE
|
Boston Therapeutics
LAWRENCE, MA--(Marketwired - Oct 13, 2016) - Boston Therapeutics, Inc. (OTCQB: BTHE) - Today Boston Therapeutics and Advance Pharmaceutical Co., Ltd., which holds a license for the...
Boston Therapeutics Reports Positive Topline Data From Proof of Concept Asia Trial
06 oct. 2016 08h22 HE
|
Boston Therapeutics
LAWRENCE, MA--(Marketwired - Oct 6, 2016) - Boston Therapeutics, Inc. (OTCQB: BTHE) and its Asian partner Advance Pharmaceutical Company Limited, Hong Kong presented today the positive topline data...
Boston Therapeutics Completes Private Offering, Appoints New CEO
03 oct. 2016 13h15 HE
|
Boston Therapeutics
LAWRENCE, MA--(Marketwired - Oct 3, 2016) - Boston Therapeutics, Inc. (OTCQB: BTHE) ("Boston Therapeutics" or the "Company") announced that it closed a private placement yielding gross proceeds to...